Atherosclerosis
Volume 211, Issue 1 , Pages 90-95 , July 2010

Accumulation and expression of serum amyloid P component in human atherosclerotic lesions

  • Zhiqing Song

      Affiliations

    • Department of Pediatrics, University of Kentucky Medical School, Lexington, KY 40536, United States
    • Taian Central Hospital, Taian, Shandong 271000, PR China
    • ,
  • Lei Cai

      Affiliations

    • Department of Internal Medicine, University of Kentucky Medical School, Lexington, KY 40536, United States
    • ,
  • Ling Guo

      Affiliations

    • Department of Pediatrics, University of Kentucky Medical School, Lexington, KY 40536, United States
    • ,
  • Yoshitane Tsukamoto

      Affiliations

    • National Cardiovascular Center, Osaka, Japan
    • Hyogo College of Medicine, Hyogo, Japan
    • ,
  • Chikao Yutani

      Affiliations

    • National Cardiovascular Center, Osaka, Japan
    • ,
  • Xiang-An Li

      Affiliations

    • Department of Pediatrics, University of Kentucky Medical School, Lexington, KY 40536, United States
    • Corresponding Author InformationCorresponding author at: BBSRB B365, 741 South Limestone Street, Lexington, KY 40536, United States. Tel.: +1 859 257 5113; fax: +1 859 257 2120.

Received 12 November 2009 ,Revised 13 January 2010 ,Accepted 28 January 2010.

References 

  1. Gewurz H, Zhang X-H, Lint TF. Structure and function of the pentraxins. Curr. Opin. Immunol. 1995;7:54–64
  2. Manfredi AA, Rovere-Querini P, Bottazzi B, Garlanda C, Mantovani A. Pentraxins, humoral innate immunity and tissue injury. Curr. Opin. Immunol. 2008;20:538–544
  3. Emsley J, White HE, O’Hara BP, et al. Structure of pentameric human serum amyloid P component. Nature. 1994;367:338–345
  4. Pepys MB, Baltz ML, de Beer FC, et al. Biology of serum amyloid P component. Ann. N Y Acad. Sci. 1982;389:286–298
  5. Pepys MB, Dyck RF, de Beer FC, Skinner M, Cohen AS. Binding of serum amyloid P-component (SAP) by amyloid fibrils. Clin. Exp. Immunol. 1979;38:284–293
  6. Botto M, Hawkins PN, Bickerstaff MC, et al. Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene. Nat. Med. 1997;3:855–859
  7. Breathnach SM, Kofler H, Sepp N, et al. Serum amyloid P component binds to cell nuclei in vitro and to in vivo deposits of extracellular chromatin in systemic lupus erythematosus. J. Exp. Med. 1989;170:1433–1438
  8. Pepys MB, Butler PJ. Serum amyloid P component is the major calcium-dependent specific DNA binding protein of the serum. Biochem. Biophys. Res. Commun. 1987;148:308–313
  9. Bickerstaff MC, Botto M, Hutchinson WL, et al. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nat. Med. 1999;5:694–697
  10. Buckley DI, Fu R, Freeman M, Rogers K, Helfand M. C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann. Intern. Med. 2009;151:483–495
  11. Li XA, Hatanaka K, Ishibashi-Ueda H, Yutani C, Yamamoto A. Characterization of serum amyloid P component from human aortic atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 1995;15:252–257
  12. Li XA, Yutani C, Shimokado K. Serum amyloid P component associates with high density lipoprotein as well as very low density lipoprotein but not with low density lipoprotein. Biochem. Biophys. Res. Commun. 1998;244:249–252
  13. Jenny NS, Arnold AM, Kuller LH, Tracy RP, Psaty BM. Serum amyloid P and cardiovascular disease in older men and women: results from the Cardiovascular Health Study. Arterioscler. Thromb. Vasc. Biol. 2007;27:352–358
  14. Stewart CR, Haw A, Lopez R, et al. Serum amyloid P colocalizes with apolipoproteins in human atheroma: functional implications. J. Lipid Res. 2007;48:2162–2171
  15. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1995;92:1355–1374
  16. Sato M, Sugano N, Ohzono K, et al. Apoptosis and expression of stress protein (ORP150, HO1) during development of ischaemic osteonecrosis in the rat. J. Bone Joint Surg. Br. 2001;83-B:751–759
  17. van der Westhuyzen DR, Cai L, de Beer MC, de Beer FC. Serum amyloid A promotes cholesterol efflux mediated by scavenger receptor B-I. J. Biol. Chem. 2005;280:35890–35895
  18. Haidar B, Denis M, Krimbou L, Marcil M, Genest J. cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts. J. Lipid Res. 2002;43:2087–2094
  19. Fournier N, Francone O, Rothblat G, et al. Enhanced efflux of cholesterol from ABCA1-expressing macrophages to serum from type IV hypertriglyceridemic subjects. Atherosclerosis. 2003;171:287–293

PII: S0021-9150(10)00095-X

doi: 10.1016/j.atherosclerosis.2010.01.046

Atherosclerosis
Volume 211, Issue 1 , Pages 90-95 , July 2010

Article Tools

* Image Usage & Resolution